CYP2D6 Genotype and Cognitive Deficits in Methamphetamine Users with/without HIV
Written by Mariana Cherner, Ph.D.
Agency: NIH
Agency Award Number: R01 DA035736
To determine in a retrospective clinical sample whether genetic polymorphisms coding for differences in methamphetamine metabolism are related to differences in cognitive sequelae among former methamphetamine addicts with and without HIV infection.

Dr. Scott Letendre, MD, presented at the HIV and Aging Symposium 2026.